Caprock Group LLC Buys New Stake in DENTSPLY SIRONA Inc. $XRAY

Caprock Group LLC purchased a new position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund purchased 60,387 shares of the medical instruments supplier’s stock, valued at approximately $766,000.

Other institutional investors have also bought and sold shares of the company. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in shares of DENTSPLY SIRONA during the 1st quarter valued at about $26,000. Parkside Financial Bank & Trust grew its position in DENTSPLY SIRONA by 620.6% in the second quarter. Parkside Financial Bank & Trust now owns 1,715 shares of the medical instruments supplier’s stock worth $27,000 after acquiring an additional 1,477 shares in the last quarter. True Wealth Design LLC increased its stake in DENTSPLY SIRONA by 273.0% during the second quarter. True Wealth Design LLC now owns 2,376 shares of the medical instruments supplier’s stock worth $38,000 after acquiring an additional 1,739 shares during the last quarter. Central Pacific Bank Trust Division raised its position in DENTSPLY SIRONA by 100.0% during the third quarter. Central Pacific Bank Trust Division now owns 4,000 shares of the medical instruments supplier’s stock valued at $51,000 after purchasing an additional 2,000 shares during the period. Finally, IFP Advisors Inc lifted its stake in shares of DENTSPLY SIRONA by 924.5% in the 2nd quarter. IFP Advisors Inc now owns 3,811 shares of the medical instruments supplier’s stock valued at $61,000 after purchasing an additional 3,439 shares during the last quarter. Institutional investors own 95.70% of the company’s stock.

Insider Activity

In related news, Director Gregory T. Lucier sold 82,200 shares of the business’s stock in a transaction that occurred on Monday, December 8th. The shares were sold at an average price of $11.14, for a total transaction of $915,708.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. 0.52% of the stock is currently owned by insiders.

DENTSPLY SIRONA Stock Up 1.1%

Shares of NASDAQ XRAY opened at $12.95 on Tuesday. DENTSPLY SIRONA Inc. has a 12-month low of $9.85 and a 12-month high of $19.27. The stock’s fifty day simple moving average is $12.15 and its two-hundred day simple moving average is $12.51. The stock has a market capitalization of $2.58 billion, a PE ratio of -2.93, a price-to-earnings-growth ratio of 1.02 and a beta of 1.01. The company has a current ratio of 1.47, a quick ratio of 0.99 and a debt-to-equity ratio of 1.36.

DENTSPLY SIRONA Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, January 9th. Stockholders of record on Friday, December 26th were issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 4.9%. The ex-dividend date was Friday, December 26th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -14.48%.

Analyst Ratings Changes

XRAY has been the topic of several analyst reports. Wells Fargo & Company cut their target price on DENTSPLY SIRONA from $15.00 to $12.00 and set an “equal weight” rating on the stock in a research report on Friday, November 7th. Barrington Research reaffirmed an “outperform” rating and set a $14.00 price objective on shares of DENTSPLY SIRONA in a research note on Monday, January 5th. Stifel Nicolaus set a $13.00 target price on shares of DENTSPLY SIRONA in a research note on Thursday, November 6th. Robert W. Baird lowered their target price on shares of DENTSPLY SIRONA from $14.00 to $12.00 and set a “neutral” rating for the company in a report on Tuesday, December 16th. Finally, Barclays initiated coverage on shares of DENTSPLY SIRONA in a report on Monday, December 8th. They set an “underweight” rating and a $12.00 price target on the stock. Two investment analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the company. According to MarketBeat.com, DENTSPLY SIRONA presently has an average rating of “Reduce” and a consensus price target of $14.25.

About DENTSPLY SIRONA

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.